Clinical Trial Update: A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A modular Phase 1/2 clinical trial of CT7439 for solid malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CT7439

Snippet

Sponsor: Carrick Therapeutics Limited | Conditions: Solid Malignancies | Phase 1, Phase 2 | Status: RECRUITING